Medtronic's $538 Mil. Physio-Control Buy Adds External Defibrillator Line
This article was originally published in The Gray Sheet
Medtronic plans to accelerate the development of a prescription home-use market for automated external defibrillators upon completion of its $538 mil. acquisition of Physio-Control.
You may also be interested in...
Medtronic's planned spinoff of its Physio-Control external defibrillator business could allow accelerated growth of both companies, according to the firm
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.